Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on April 23, 2025
Bluejay Therapeutics Announces Upcoming Presentation of Preclinical Data in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at European Association for the Study of the Liver (EASL) Congress 2025
GlobeNewswire
·
April 23, 2025
REDWOOD CITY, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Bluejay Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing therapeutics for serious viral and liver diseases, today announced it will present …
Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers
GlobeNewswire
·
April 23, 2025
The addition of a seasoned VP of Marketing compliments the recent hiring of the Company’s VP of Sales to establish its commercialization readiness infrastructure Positive data from the recently published pivotal study raises confidence that LIBERTY® will …
Enlivex Therapeutics to Showcase Allocetra’s Potential in Osteoarthritis at OARSI 2025 World Congress
GlobeNewswire
·
April 23, 2025
Presentations to underscore AllocetraTM’s novel mechanism targeting immune imbalance in joint disease Ness-Ziona, Israel, April 23, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming …
Clearmind Medicine Completes the Initiation of its Alcohol Use Disorder Phase I/IIa Clinical Trial at all Current Clinical Sites
GlobeNewswire
·
April 23, 2025
The Company is now preparing for the enrollment of the first patient to receive Clearmind’s innovative treatment as part of the trial Vancouver, Canada, April 23, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or …
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Detection of H. pylori Infection
GlobeNewswire
·
April 23, 2025
10-minute test enables detection of Helicobacter pylori, a leading cause of peptic ulcers, dyspepsia, and gastric cancer Approximately 80% of gastric cancer cases are linked to H. pylori infection; WHO classifies H. pylori as a Class 1 carcinogen This test …
Hospice Choices: VITAS® Healthcare Expands in Austin, Texas
GlobeNewswire
·
April 23, 2025
AUSTIN, Texas, April 23, 2025 (GLOBE NEWSWIRE) -- Responding to the growing demand for high-quality hospice care in Central Texas, VITAS Healthcare has expanded its reach in the Austin area by opening a new administrative office in Pflugerville. With the …
VivoSim to Carry Forward Organovo 3D Bioprinting
GlobeNewswire
·
April 23, 2025
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (the “Company”) announced that it will carry forward its 3D bioprinting and legacy technology as VivoSim Labs, Inc. A name change of the Company to VivoSim Labs, Inc. will …
NATIONAL ORGANIZATIONS UNITE TO PREPARE EARLY CHILDCARE FACILITIES FOR RISING INCIDENCE OF FOOD ALLERGIES
GlobeNewswire
·
April 23, 2025
Richmond, Virginia, April 23, 2025 (GLOBE NEWSWIRE) -- A multi-disciplinary group of childcare professionals, healthcare providers, parents, and advocates, spearheaded by Kaléo, have united to form the Early Childhood Anaphylaxis Collaborative ( …
Phathom Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide Business Update on Thursday, May 1, 2025
GlobeNewswire
·
April 23, 2025
• Management to host conference call on Thursday, May 1, 2025, at 8:00 am EDT FLORHAM PARK, N.J., April 23, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel …
Arialief Reviews And Complaints (INVESTIGATIVE REPORT) Safe Ingredients for Neuropathy Relief or Over Hype?
GlobeNewswire
·
April 23, 2025
MIAMI, April 23, 2025 (GLOBE NEWSWIRE) -- Arialief is a nerve-support supplement that has recently seen a rise in popularity. Like many dietary supplements aimed at relieving sciatic discomfort, it claims to deliver fast, effective results without side …
Rhythm Pharmaceuticals to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025
GlobeNewswire
·
April 23, 2025
BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will …
Codetta Bio to Launch Concerto™ System at AACR 2025 with Exhibitor Spotlight Presentation
GlobeNewswire
·
April 23, 2025
DURHAM, N.C., April 23, 2025 (GLOBE NEWSWIRE) -- Codetta Bio, a leader in multi-omics innovation, today announced its presence at the American Association for Cancer Research (AACR) Annual Meeting 2025, where the company will officially launch the Concerto …
Daré Bioscience to Present at the Fierce Pharma Engage Summit on Breaking Barriers and Building Access: Communicating Bold Moves in Women’s Health Innovation
GlobeNewswire
·
April 23, 2025
Presentation will focus on corporate communications strategies for unveiling an innovative expanded business strategy Daré recently announced its new dual-path approach for its proprietary Sildenafil Cream formulation and is targeting availability via …
Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore
GlobeNewswire
·
April 23, 2025
The STCC Unified PD1/PDL1 Evaluation of Response (SUPER) study is a multi-institutional study led by STCC with the goal of identifying predictors of PD1 immunotherapy response in an Asian real-world setting, bringing together Singapore’s public healthcare …
Plus Therapeutics Announces Biotech Industry Veteran Kyle Guse Joins its Board of Directors
GlobeNewswire
·
April 23, 2025
HOUSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, …
Catheter Precision to Acquire Assets in Development for Late-Stage Treatment for Acute Decompensated Heart Failure
GlobeNewswire
·
April 23, 2025
Initial Clinical Studies Completed with Significant Positive Results The Cleveland Clinic Foundation, Abbott Laboratories and a New Era Associates (NEA) fund to Acquire Economic Interests in VTAK Fort Mill, S.C., April 23, 2025 (GLOBE NEWSWIRE) -- Catheter …
Recce Pharmaceuticals Receives Approval for Additional Phase II Trial of RECCE® 327 Topical Gel for Diabetic Foot Infections
GlobeNewswire
·
April 23, 2025
Human Research Ethics Committee (HREC) approval received to allow up to 20 additional patients access to RECCE® 327 Topical Gel (R327G) treatment under existing open-label study protocol Program enables access to R327G for diabetic foot infections (DFI), …
Kestra Medical Technologies to Showcase Innovation in Sudden Cardiac Arrest Protection and Recovery at Heart Rhythm 2025
GlobeNewswire
·
April 23, 2025
KIRKLAND, Wash., April 23, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS) (“Kestra”), a wearable medical device and digital healthcare company, announced today it will exhibit at Heart Rhythm 2025, the annual meeting of the Heart …
Beghou Consulting Prepares for Next Phase of Growth, Names Adrienne Lovink, Chief Services Officer, to Succeed Beth Beghou, Founder and CEO
GlobeNewswire
·
April 23, 2025
EVANSTON, Ill., April 23, 2025 (GLOBE NEWSWIRE) -- Beghou Consulting, a leading provider of data, analytics, and technology solutions for life sciences commercialization, today announced that Adrienne Lovink, Chief Services Officer, will assume the role of …
Calidi Biotherapeutics Announces Chief Executive Officer Transition and Appointment of Eric Poma, Ph.D. as CEO and Director
GlobeNewswire
·
April 23, 2025
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the succession of its Chief …